Frank L. Porfido
Nessuna posizione attualmente
Profilo
Frank L.
Porfido held the position of Chief Financial Officer at Tyme Technologies, Inc. in 2021 and Vice President-Finance at UroGen Pharma, Inc. from 2019 to 2021.
He earned an MBA from Fairleigh Dickinson University and an undergraduate degree from Pace University.
Precedenti posizioni note di Frank L. Porfido
| Società | Posizione | Fine |
|---|---|---|
| TYME TECHNOLOGIES, INC. | Director of Finance/CFO | 16/09/2022 |
| UroGen Pharma, Inc. | Corporate Officer/Principal | 01/05/2021 |
Formazione di Frank L. Porfido
| Fairleigh Dickinson University | Masters Business Admin |
| Pace University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
Tyme Technologies, Inc.
 Tyme Technologies, Inc. Pharmaceuticals: MajorHealth Technology Tyme Technologies, Inc. operates as a biotechnology company, which engages in the development and commercialization of cancer therapies. It offers a clinical program named SM-88 which is a novel, oral, and monotherapy investigational agent that aims to disrupt the cancer cell's protein synthesis. The company was founded by Steve Hoffman and Michael Demurjian on November 22, 2011 and is headquartered in Bedminster, NJ. | Health Technology |
| UroGen Pharma, Inc. | Health Technology |
- Borsa valori
- Insiders
- Frank L. Porfido
